Vicarious Surgical Q1 2024 Adj EPS $(0.09) Beats $(0.10) Estimate
Portfolio Pulse from Benzinga Newsdesk
Vicarious Surgical (NYSE:RBOT) reported Q1 2024 adjusted EPS losses of $(0.09), surpassing the consensus estimate of $(0.10) by 10%. This represents a 47.06% improvement over the $(0.17) per share losses from the same period last year.
April 29, 2024 | 8:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Vicarious Surgical reported a smaller than expected loss per share for Q1 2024, showing significant improvement over the previous year.
Beating EPS estimates typically has a positive impact on stock prices as it indicates better financial health and performance than anticipated by the market. The significant year-over-year improvement further highlights the company's progress in reducing losses, which could boost investor confidence.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100